Using a novel cellular platform to optimize CRISPR/CAS9 technology for the gene therapy of AIDS
Crossref DOI link: https://doi.org/10.1007/s13238-017-0453-z
Published Online: 2017-08-18
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
He, Jingjin
Zhang, Thanutra
Fu, Xuemei
License valid from 2017-08-18